New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2013
04:55 EDTLIFE, LIFE, LIFE, SI, SI, SI, BIOL, BIOL, BIOL, IVC, IVC, IVC, VAR, VAR, VAR, ARAY, ARAY, ARAY, CPHD, CPHD, CPHD, MASI, MASI, MASI, HRC, HRC, HRC, RHHBY, RHHBY, RHHBY, MCK, MCK, MCKWorldwide Business Research to host a conference
Field Service Medical Conference is being held in San Diego on February 19-21.
News For LIFE;RHHBY;HRC;MASI;CPHD;ARAY;VAR;IVC;BIOL;SI;MCK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
12:20 EDTIVCInvacare to realize about $13.7M in net proceeds from sale of rentals businesses
Invacare announced that it has completed the sale of its United States medical device rentals businesses for long-term care facilities for approximately $15.5M in cash, subject to certain post-closing adjustments. Matthew Monaghan, Chairman, President and CEO, said, ''The sale of our United States rentals businesses allows us to narrow our focus on improving profitability in our core business, including the design, manufacture and distribution of medical devices. We are pleased to complete this divestiture, and I want to thank the entire rentals team for their contributions to Invacare.'' Subject to certain post-closing adjustments and any restructuring charges, Invacare preliminarily estimates it will realize net proceeds from the sale of the rentals businesses of approximately $13.7M, net of tax and expenses. For the three months ended March 31, net sales for the rentals businesses were approximately $7.2M, and loss before tax and any pro forma adjustments was approximately $0.6M.
10:04 EDTCPHDCepheid issued a long-term Sell rating at Off Wall Street Research
Subscribe for More Information
July 1, 2015
08:46 EDTRHHBYExelixis says FDA extends PDUFA action date for cobimetinib NDA
Subscribe for More Information
June 30, 2015
05:30 EDTRHHBYGenentech reports ocrelizumab Phase III studies met primary, secondary endpoints
Subscribe for More Information
June 26, 2015
10:00 EDTCPHDOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:05 EDTCPHDCepheid upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum upgraded Cepheid to Buy and raised its price target to $75 from $52. The firm said Cepheid is rapidly expanding its clinical offering and customer reach and is emerging as the leading platform for molecular diagnostics.
June 25, 2015
14:03 EDTRHHBYRoche initiated with a Buy at HSBC
Subscribe for More Information
June 24, 2015
09:07 EDTRHHBYCAR-T cancer drug researchers seen as M&A targets, Bloomberg says
Juno Therapeutics (JUNO), Kite Pharma (KITE) and Bluebird Bio (BLUE) are trading well above their IPO levels as takeovers predictions have spurred interest and share increases for the developers of CAR-T gene therapies, said Bloomberg's "Real M&A" column, quoting Dimo Dimov, a professor at the University of Bath’s School of Management, as having said that companies such as Pfizer (PFE), Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) are "closely watching" the firms. Cellectis (CLLS), which is working with Pfizer on its own approach to CAR-T therapy, has said it wants to bring its therapy to market and doesn’t anticipate a sale, the report noted. Reference Link
08:05 EDTMCK McKesson reaffirms FY16 EPS $12.20-$12.70, consensus $12.59
Subscribe for More Information
June 22, 2015
08:17 EDTMCKMcKesson appoints Kathy McElliogott as EVP, CIO, CTO
Subscribe for More Information
08:09 EDTMASIMasimo receives CE Mark for MightySat Rx pulse oximeter
Subscribe for More Information
June 19, 2015
15:49 EDTMCKMcKesson to host investor day
Investor meeting to be held on June 24 at 9 am. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use